NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market Wednesday that its second quarter revenues rose 6 percent compared to Q2 of 2015.

For the period ended Jan. 31, 2015, the company reported total revenues of $24.6 million, up from $23.1 million in Q2 of 2015. Clinical lab services revenues rose 19 percent to $17.5 million from $14.7 million a year ago. The company credited increased demand for molecular diagnostics testing at higher reimbursement rates for the increase.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.